返回
Takeda Pharmaceutical Co Ltd（TAK）價格
TAK 股價走勢圖
TAK 收益
Takeda Pharmaceutical Co Ltd
$16.61
1.96%
$0.32
收盤價：Jan 26, 16:00:00 GMT-5
$16.7
0.54%
$0.08
盤後：Jan 26, 16:41:20 GMT-5
最新獲利結果： Q2 '26
報導： 2025-10-30
歷史收益
每季
年度
EPS
收入
Earnings FAQ
TAK 最近的每股盈餘與預期相比如何？
Takeda Pharmaceutical Co Ltd TAK 上一季度的收入表現如何？
Takeda Pharmaceutical Co Ltd 的收入預期是多少？
Takeda Pharmaceutical Co Ltd 的盈利品質評分是多少？
Takeda Pharmaceutical Co Ltd 何時發布財報？
Takeda Pharmaceutical Co Ltd 的預期收益是多少？
Takeda Pharmaceutical Co Ltd 是否超出收益預期？
關鍵數據
前收市價
$16.29
開盤價
$16.42
當日範圍
$16.41 - $16.7
52週區間
$12.8 - $16.7
交易量
2.9M
平均成交量
2.8M
每股盈餘 (TTM)
0.06
股息收益率
--
市值
$52.7B
什麼是 Takeda Pharmaceutical Company L？
Takeda Pharmaceutical Co., Ltd. engages in the research and development, manufacture, import and export sale, and marketing of pharmaceutical drugs. The company is headquartered in Chuo-Ku, Tokyo-To and currently employs 47,455 full-time employees. The firm focuses on the main business areas of gastrointestinal diseases, rare diseases, plasma derivatives (immune diseases), oncology (cancer), and neuroscience (neuropsychiatric diseases). The firm focuses on three research and development areas: innovative biopharmaceuticals with the focus on gastrointestinal and inflammatory diseases, neuroscience, and oncology, plus plasma derivatives and vaccines. Most of the pharmaceuticals treat rare diseases in the focus disease areas and the plasma derivatives area. The firm operates in Japan, the United States, Europe, and China.